FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

Hyponatremia in Man Reveals Isolated Aldosterone Deficiency

Persistent hyponatremia despite treatment prompts further evaluation, revealing isolated aldosterone deficiency despite normal adrenal function and leading to effective therapy.

How to Spot Anxiety in General Practice

Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and collaborative care may help GPs identify and manage them earlier.

Australia Seeks to Reverse Surge in Syphilis Cases

Syphilis has reemerged as a major public health threat across Australia but signs indicate that things might be improving.

Why This Painful Disorder Can Take a Decade-Plus to Diagnose

A connective tissue disorder with wide-ranging symptoms, hypermobile Ehlers-Danlos syndrome can lead to serious complications and harm from a medical system that doesn’t understand it.

Finding the Mystery to Trigger-Induced Atrial Fibrillation

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

Getting Blood Into Ambulances Matters in Trauma Cases

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Latest News

Persistent hyponatremia despite treatment prompts further evaluation, revealing isolated aldosterone deficiency despite normal adrenal function and leading to effective therapy.

Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and collaborative care may help GPs identify and manage them earlier.

Syphilis has reemerged as a major public health threat across Australia but signs indicate that things might be improving.

A connective tissue disorder with wide-ranging symptoms, hypermobile Ehlers-Danlos syndrome can lead to serious complications and harm from a medical system that doesn’t understand it.

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

News All Time

Cancer Recurrence: What Awakens Dormant Tumor Cells?

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Expanded Pediatric Use for Roflumilast Under FDA Review

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

Model Spots Kids With Anaphylaxis Who Do Not Require ED Care

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Inside Isolation Units for Highly Contagious Diseases

The Spanish model highlights the infrastructure, training, and containment measures required for high-risk infectious disease care.

Education Nudges Patients With CKD Away From Haemodialysis

Structured predialysis education may help patients with chronic kidney disease stages 4 and 5 to choose peritoneal dialysis over haemodialysis, a Polish study finds.

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

The Essential Clinical Research You’re Probably Not Reading

Qualitative research has long been viewed as less rigorous and less important — but that’s changing. Here’s where to find the highest-quality studies and how to use them to help your patients.

Uveitis Patterns Vary in Relation to Spondyloarthritis Type

Patients with peripheral forms of spondyloarthritis show a higher prevalence of different uveitis patterns than those with axial forms.

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

Pernicious Anemia: How a Fatal Disease Became Treatable

Once nearly always fatal, pernicious anemia became treatable through a series of discoveries linking the stomach, liver, and ultimately vitamin B12.

AI Is Making Uneven Inroads in Pulmonary Medicine

AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and prediction, but significant gaps between development and deployment.

Pain Persists Despite Low Inflammation in Many With Early RA

Patients newly diagnosed with rheumatoid arthritis often experience unacceptable pain at 2 years despite having low levels of inflammation, a study finds.

Can CRISPR Make CAR T Safer and More Scalable?

Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease.

Recommended News For You

Scientists identify dual protein targets to weaken pancreatic cancer defenses

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised?

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

Researchers publish action plan to address appendiceal cancer enigmas

Recommended Articles For You

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments 

Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence 

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management 

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

2.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

3.

Black and Hispanic children with high-risk neuroblastoma have worse outcomes despite standardized treatment

4.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

5.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

1.

Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities

2.

The Mysterious World of Petechiae: Exploring Causes and Treatments

3.

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer

4.

Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax 

5.

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

4.

Navigating the Complexities of Ph Negative ALL - Part VII

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot